We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.
Reported problems with the supply of an animal medicine and the date when the issue is expected to be resolved.
Check the tariff classification for surface-active preparation for washing the skin and the hair (gel 2-in-1).
We work for a secure and prosperous United Kingdom with global reach and influence. We will protect our people, territories, values and interests at home and overseas, through strong armed forces and in partnership with allies, to ensure our security,...
Get help to classify herbal medicines, vitamins, food preparations, supplements and tonics for import and export.
Collection of information and guidance for patients and for healthcare professionals on the reproductive risks of valproate and new safety measures introduced to reduce these risks.
As a vet or pharmacist, you must follow legal requirements when working with controlled drugs in veterinary medicine.
Batches of some products made by Legency Remedies Pvt Ltd have been found to contain a bacteria called Ralstonia pickettii (R. pickettii). All potentially affected batches are being recalled following an MHRA investigation.
Atnahs Pharma UK Ltd has informed the MHRA that the batches of Clobazam Atnahs 5mg/5ml and 10mg/5ml Oral Suspension listed in this notification do not contain the most up to date safety information.
This document details the service standards of the Veterinary Medicines Directorate (VMD)
medac GmbH (t/a medac Pharma LLP) is recalling the products and respective batches in this notification due to pink discolouration of the dacarbazine solution immediately after reconstitution (after correct preparation and storage).
Information on the reporting, investigation and management of acute flaccid paralysis (AFP) and acute flaccid myelitis (AFM).
Diagnosis and epidemiology of Mycoplasma pneumoniae.
Travel and clinical advice on Cyclospora including characteristics, symptoms, diagnosis and epidemiology.
Batch recall alert for human eye gels that may be prescribed by vets and used under the cascade.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.